Announcement on Voluntary Disclosure of Obtaining Lot Release by Company's Quadrivalent Influenza Vaccine for 2023-2024 Influenza Season

About this update from Jiangsu Gdk Biotechnology Co., Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Lot Release by Company's Quadrivalent Influenza Vaccine for 2023-2024 Influenza SeasonThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:" target="_blank">View Attachment

View stock analysis, news, and events for Jiangsu Gdk Biotechnology Co., Ltd. Class A